GHUCCTS

About Us

Share This

About GHUCCTS

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is a multi-institutional consortium of medical research institutions forged from a desire to promote clinical research and translational science. The members of the GHUCCTS consortium are: Georgetown University (GU), Howard University (HU), MedStar Health Research Institute (MHRI), Oak Ridge National Laboratory (ORNL), and the Washington Veteran’s Affairs Medical Center (VAMC).

Through multiple partnerships and collaborations among the member institutions, GHUCCTS is transforming clinical research and translational science in order to bring new scientific advances to improve health care more efficiently and quickly. 

GHUCCTS was founded on five basic principles that have been endorsed by each of the member institutions. These serve to identify the overall purpose of the consortium, as well as key aspects of its research activities, governance, and focus. These principles form the foundation of the consortium itself, as well as the GHUCCTS programs of research and education.


GHUCCTS Founding Principles

  1. The primary goal of GHUCCTS is to improve the infrastructure that supports high quality multidisciplinary clinical and translational research, both via inter-institutional collaborations across all GHUCCTS institutions as well as multicenter clinical trials across the national CTSA consortium, with increasing levels of speed and efficiency, and to develop innovative informatics methods to speed and enhance translation.

  2. We continue to develop GHUCCTS as a model of inter-institutional collaboration that leverages the strengths and attributes of its diverse participating institutions

  3. Leverage our location, expertise, and the co-leadership of a minority-serving institution to design and implement research that will have a high impact on all populations that we serve, including people of diverse racial, ethnic, and cultural backgrounds, people with disabilities, older adults, and veterans.

  4. Design and disseminate vibrant and innovative educational programs at multiple levels (undergraduate, medical school, graduate, study coordinators, research nurses, and junior faculty) that promote team science and provides the highest quality of career development training for the clinical and translational investigators of the future.

  5. Draw from and contribute to the collective effort of the National CTSA consortium to advance GHUCCTS, the National Center for Advancing Translational Science (NCATS), and the CTSA consortium.
Related News

2026 K12 Early-Stage Investigators - Request for Letters of Intent

Apr 28, 2026

We are pleased to announce the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) 2026 K12 Mentored Research Career Development Program in clinical and translational science, which we anticipate beginning in early fall 2026. Letters of Intent are due on June 1, 2026.

Request for Applications: 2026-2027 Predoctoral T32 Translational Biomedical Science Program

Apr 28, 2026

We are pleased to announce the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) 2026 Predoctoral T32 Translational Biomedical Science Research Program, which we anticipate beginning in early fall 2026. Applications are due on July 1, 2026; however, submit a Letter of Intent as soon as possible to receive helpful feedback before the full application is due.

GHUCCTS is featured in the Georgetown University Medical Center’s Health Science Weekly

Apr 22, 2026

This is a series that will be featured in their 2026 spring issue about the impact of GHUCCTS as a home for translational research.

Close